These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 2536522)

  • 1. Human macrophages can express the Hodgkin's cell-associated antigen Ki-1 (CD30).
    Andreesen R; Brugger W; Löhr GW; Bross KJ
    Am J Pathol; 1989 Jan; 134(1):187-92. PubMed ID: 2536522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaplastic large-cell Ki-1 malignant lymphomas. Recognition, biological and clinical implications.
    Kinney MC; Greer JP; Glick AD; Salhany KE; Collins RD
    Pathol Annu; 1991; 26 Pt 1():1-24. PubMed ID: 1849627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin's disease and CD30-positive anaplastic large cell lymphomas--a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study.
    Leoncini L; Del Vecchio MT; Kraft R; Megha T; Barbini P; Cevenini G; Poggi S; Pileri S; Tosi P; Cottier H
    Am J Pathol; 1990 Nov; 137(5):1047-57. PubMed ID: 2173409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ki-1 (CD30) antigen is released by Ki-1-positive tumor cells in vitro and in vivo. I. Partial characterization of soluble Ki-1 antigen and detection of the antigen in cell culture supernatants and in serum by an enzyme-linked immunosorbent assay.
    Josimovic-Alasevic O; Dürkop H; Schwarting R; Backé E; Stein H; Diamantstein T
    Eur J Immunol; 1989 Jan; 19(1):157-62. PubMed ID: 2537734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of an Mr 70,000 antigen associated with Reed-Sternberg cells and interdigitating reticulum cells.
    Hsu PL; Hsu SM
    Cancer Res; 1990 Jan; 50(2):350-7. PubMed ID: 2153049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD30/Ki-1-positive anaplastic large cell lymphoma preceded by Hodgkin's disease.
    Tsurumi H; Takahashi T; Moriwaki H; Muto Y
    Int J Hematol; 1992 Aug; 56(1):99-102. PubMed ID: 1327272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of the Hodgkin's disease-associated antigen Ki-1 in cutaneous infiltrates.
    van der Putte SC; Toonstra J; van Wichen DF; van Unnik JA; van Vloten WA
    Acta Derm Venereol; 1988; 68(3):202-8. PubMed ID: 2455412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and expression of CT45 in Hodgkin's lymphoma.
    Heidebrecht HJ; Claviez A; Kruse ML; Pollmann M; Buck F; Harder S; Tiemann M; Dörffel W; Parwaresch R
    Clin Cancer Res; 2006 Aug; 12(16):4804-11. PubMed ID: 16914565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's disease.
    Engert A; Burrows F; Jung W; Tazzari PL; Stein H; Pfreundschuh M; Diehl V; Thorpe P
    Cancer Res; 1990 Jan; 50(1):84-8. PubMed ID: 2152774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human embryonal epithelial cells of the developing small intestinal crypts can express the Hodgkin-cell associated antigen Ki-1 (CD30) in spontaneous abortions during the first trimester of gestation.
    Tamiolakis D; Venizelos J; Lambropoulou M; Nikolaidou S; Bolioti S; Tsiapali M; Verettas D; Tsikouras P; Chatzimichail A; Papadopoulos N
    Theor Biol Med Model; 2005 Jan; 2():1. PubMed ID: 15644135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypes and phorbol ester-induced differentiation of human histiocytic lymphoma cell lines (U-937 and SU-DHL-1) and Reed-Sternberg cells.
    Hsu SM; Hsu PL
    Am J Pathol; 1986 Feb; 122(2):223-30. PubMed ID: 3511721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopathology of Hodgkin's disease. Characterization of Reed-Sternberg cells with monoclonal antibodies.
    Strauchen JA; Dimitriu-Bona A
    Am J Pathol; 1986 May; 123(2):293-300. PubMed ID: 3085509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma.
    Pallesen G; Hamilton-Dutoit SJ
    Am J Pathol; 1988 Dec; 133(3):446-50. PubMed ID: 2849300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Leu-3a antibody reactivity with Reed-Sternberg cells of Hodgkin's disease.
    Oka K; Mori N; Kojima M
    Arch Pathol Lab Med; 1988 Feb; 112(2):139-42. PubMed ID: 3257383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
    Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
    Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive hemophagocytosis in Ki-l positive large cell lymphoma: a case study.
    Invernizzi R; Paulli M; Rosso R; De Fazio P; Perugini O; Kindl S; Boveri E; Volpato L; Magrini U; Ascari E
    Haematologica; 1989; 74(2):155-9. PubMed ID: 2545575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.
    Stein H; Mason DY; Gerdes J; O'Connor N; Wainscoat J; Pallesen G; Gatter K; Falini B; Delsol G; Lemke H
    Blood; 1985 Oct; 66(4):848-58. PubMed ID: 3876124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease.
    Bai MC; Jiwa NM; Horstman A; Vos W; Kluin PH; Van der Valk P; Mullink H; Walboomers JM; Meijer CJ
    J Pathol; 1994 Sep; 174(1):49-55. PubMed ID: 7525910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma.
    Schnell R; Staak O; Borchmann P; Schwartz C; Matthey B; Hansen H; Schindler J; Ghetie V; Vitetta ES; Diehl V; Engert A
    Clin Cancer Res; 2002 Jun; 8(6):1779-86. PubMed ID: 12060617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.